Results 241 to 250 of about 1,985,411 (290)
Potential drug-drug interactions among hospitalised cardiac patients in Nepal: a prospective observational study. [PDF]
BMJ OpenSah BK +5 more
europepmc +1 more source
Evaluation of Potential Drug-Drug Interactions, Polypharmacy, and Prescribing Patterns of NSAIDs Among the Older Adults in a Secondary Care Setting. [PDF]
Clin Interv AgingShareef J +3 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Journal of the American Pharmacists Association: JAPhA, 2004
To develop a list of clinically important drug-drug interactions (DDIs) likely to be encountered in community and ambulatory pharmacy settings and detected by a computerized pharmacy system.Cross-sectional, one-time evaluation.United States in fall 2001.An expert panel comprising two physicians, two clinical pharmacists, and an expert on DDIs ...
Daniel C Malone +2 more
exaly +3 more sources
To develop a list of clinically important drug-drug interactions (DDIs) likely to be encountered in community and ambulatory pharmacy settings and detected by a computerized pharmacy system.Cross-sectional, one-time evaluation.United States in fall 2001.An expert panel comprising two physicians, two clinical pharmacists, and an expert on DDIs ...
Daniel C Malone +2 more
exaly +3 more sources
2018
A drug interaction occurs when the effects of a drug are altered by the effects of another drug, a vaccine, herb, foodstuff, or device. In drug–drug interactions, a precipitant drug increases or reduces the effects of an object drug by pharmaceutical, pharmacokinetic, or pharmacodynamic mechanisms.
Lopamudra Chowdhury, Om Singh
+6 more sources
A drug interaction occurs when the effects of a drug are altered by the effects of another drug, a vaccine, herb, foodstuff, or device. In drug–drug interactions, a precipitant drug increases or reduces the effects of an object drug by pharmaceutical, pharmacokinetic, or pharmacodynamic mechanisms.
Lopamudra Chowdhury, Om Singh
+6 more sources
Drug–drug interaction with statins
Expert Review of Clinical Pharmacology, 20083-hydroxy-3-methyl-glutaryl (HMG)-CoA reductase inhibitors (the so-called statins: atorvastatin, fluvastatin, pravastatin, lovastatin, rosuvastatin and simvastatin) are a well-established class of drugs in the treatment of hypercholesterolemia. Statin monotherapy is generally well tolerated, with a low frequency of adverse events.
A. Corsini, S. Bellosta
openaire +2 more sources
Drug—Drug Interactions in the Elderly
Annals of Pharmacotherapy, 2002OBJECTIVE: To detect the frequency of potential drug—drug interactions (DDIs) in an outpatient group of elderly people in 6 European countries, as well as to describe differences among countries. DATA SOURCES AND METHODS: Drug use data were collected from 1601 elderly persons living in 6 European countries.
Ingeborg K Björkman +23 more
openaire +2 more sources